trial · primary record
Trimethoprim/sulfamethoxazole (TMP/SMZ)
Eczema
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 130 |
| Primary completion | 2027-01-01 |
| Primary endpoint | Characterize microbiome alterations |
| Registry ID | NCT01631617 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:56.333Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT01631617
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.